Wood, Evan

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., Shannon, K., Harrigan, P. R., Hogg, R. S., Daly, P., et al. (2010) · The Lancet

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 780

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., & Schechter, M. T. (2003) · AIDS

HIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions

Cited by 373

Safer injection facility use and syringe sharing in injection drug users

Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005) · The Lancet

HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Cited by 294

The effectiveness of compulsory drug treatment: A systematic review

Werb, D., Kamarulzaman, A., Meacham, M. C., Rafful, C., Fischer, B., Strathdee, S. A., & Wood, E. (2016) · International Journal of Drug Policy

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 260

Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting

Tupper, K. W., McCrae, K., Garber, I., Lysyshyn, M., & Wood, E. (2018) · Drug and Alcohol Dependence

HIV, Drug Use, Sexual RiskForensic Toxicology and Drug Analysis

Cited by 238

Treatment of stimulant use disorder: A systematic review of reviews

Ronsley, C., Nolan, S., Knight, R., Hayashi, K., Klimas, J., Walley, A., Wood, E., & Fairbairn, N. (2020) · PLOS ONE

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 222

High rates of primary care and emergency department use among injection drug users in Vancouver

Kerr, T., Wood, E., Grafstein, E., Ishida, T., Shannon, K., Lai, C., Montaner, J., & Tyndall, M. W. (2005) · Journal of Public Health

HIV, Drug Use, Sexual RiskHomelessness and Social Issues

Cited by 201

Psychedelic medicine: a re-emerging therapeutic paradigm

Tupper, K. W., Wood, E., Yensen, R., & Johnson, M. W. (2015) · Canadian Medical Association Journal

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 187

Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain: A Systematic Review

Klimas, J., Gorfinkel, L., Fairbairn, N., Amato, L., Ahamad, K., Nolan, S., Simel, D. L., & Wood, E. (2019) · JAMA Network Open

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 162

Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme

Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Hogg, R. S., Montaner, J. S. G., O'Shaughnessy, M. V., & Schechter, M. T. (2002) · AIDS

HIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions

Cited by 146

Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study

Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Montaner, J. S., & Kerr, T. (2008) · BMC Public Health

HIV, Drug Use, Sexual RiskIntramuscular injections and effects

Cited by 123

Do Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?

Wood, E., Tyndall, M. W., Li, K., Lloyd-Smith, E., Small, W., Montaner, J. S. G., & Kerr, T. (2005) · American Journal of Preventive Medicine

HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Cited by 122

Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes

Palepu, A., Tyndall, M. W., Chan, K., Wood, E., Montaner, J. S., & Hogg, R. S. (2004) · Antiviral Therapy

HIV/AIDS Research and InterventionsCriminal Justice and Corrections Analysis

Cited by 121

Estimated Drug Overdose Deaths Averted by North America's First Medically-Supervised Safer Injection Facility

Milloy, M.-J. S., Kerr, T., Tyndall, M., Montaner, J., & Wood, E. (2008) · PLoS ONE

HIV, Drug Use, Sexual RiskOpioid Use Disorder Treatment

Cited by 117

Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting

Milloy, M.-J., Kerr, T., Bangsberg, D. R., Buxton, J., Parashar, S., Guillemi, S., Montaner, J., & Wood, E. (2012) · AIDS Patient Care and STDs

Homelessness and Social IssuesHIV, Drug Use, Sexual Risk

Cited by 112

Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users

Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., & Tyndall, M. W. (2004) · Harm Reduction Journal

HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Cited by 107

Prevalence and correlates of abscesses among a cohort of injection drug users

Lloyd-Smith, E., Kerr, T., Hogg, R. S., Li, K., Montaner, J. S., & Wood, E. (2005) · Harm Reduction Journal

HIV, Drug Use, Sexual RiskIntramuscular injections and effects

Cited by 102

Accessing care for injection-related infections through a medically supervised injecting facility: A qualitative study

Small, W., Wood, E., Lloyd-Smith, E., Tyndall, M., & Kerr, T. (2008) · Drug and Alcohol Dependence

HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Cited by 75

Canadian Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Disorder

Wood, E., Bright, J., Hsu, K., Goel, N., Ross, J. W. G., Hanson, A., Teed, R., Poulin, G., Denning, B., Corace, K., et al. (2023) · Canadian Medical Association Journal

Substance Abuse Treatment and OutcomesClinical practice guidelines implementation

Cited by 74

Non-Fatal Overdose Among a Cohort of Active Injection Drug Users Recruited from a Supervised Injection Facility

Milloy, M.-J. S., Kerr, T., Mathias, R., Zhang, R., Montaner, J. S., Tyndall, M., & Wood, E. (2008) · The American Journal of Drug and Alcohol Abuse

HIV, Drug Use, Sexual RiskOpioid Use Disorder Treatment

Cited by 69

Inability to access addiction treatment predicts injection initiation among street-involved youth in a Canadian setting

DeBeck, K., Kerr, T., Nolan, S., Dong, H., Montaner, J., & Wood, E. (2016) · Substance Abuse Treatment, Prevention, and Policy

HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Cited by 62

Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study

Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Sheps, S., Montaner, J. S., & Kerr, T. (2010) · BMC Public Health

HIV, Drug Use, Sexual RiskHomelessness and Social Issues

Cited by 62

Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012

Grebely, J., Lima, V. D., Marshall, B. D. L., Milloy, M.-J., DeBeck, K., Montaner, J., Simo, A., Krajden, M., Dore, G. J., Kerr, T., et al. (2014) · PLoS ONE

Hepatitis C virus researchHIV, Drug Use, Sexual Risk

Cited by 48

Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users

LLOYD-SMITH, E., HULL, M. W., TYNDALL, M. W., ZHANG, R., WOOD, E., MONTANER, J. S. G., KERR, T., & ROMNEY, M. G. (2010) · Epidemiology and Infection

Antimicrobial Resistance in StaphylococcusAntibiotic Use and Resistance

Cited by 35